Trader Alert: NiSource Inc. (NI), Atwood Oceanics, Inc. (ATW), MFA Financial, Inc. (MFA)

NiSource Inc. (NI) retreated with the stock falling -0.09% or $-0.02 to close at $22.23 on light trading volume of 2.47M compared its three months average trading volume of 2.73M. The Merrillville Indiana 46410 based company operating under the Diversified Utilities industry has been trending up for the last 52 weeks, with the shares price now 7.15% up for the period and up by 1.21% so far this year. With price target of $24.04 and a 9.56% rebound from 52-week low, NiSource Inc. has plenty of upside potential, making it a hold with a view buy.

NiSource Inc., an energy holding company, provides natural gas, electricity, and other products and services in the United States. The company operates through two segments, Gas Distribution Operations and Electric Operations. It provides natural gas service and transportation to residential, commercial, and industrial customers; generates, transmits, and distributes electricity; and provides wholesale and transmission transaction services. The company serves approximately 3.4 million natural gas customers and 463,000 electric customers in in Ohio, Pennsylvania, Virginia, Kentucky, Maryland, Indiana, and Massachusetts. It also owns and operates 3 coal-fired electric generating stations with a net capability of 2,540 megawatts (MW), 3 gas-fired generating units with a net capability of 196 MW, and 2 hydroelectric generating plants with a net capability of 10 MW, as well as a combined cycle gas turbine plant with a capacity of 535 MW. The company was formerly known as NIPSCO Industries, Inc. and changed its name to NiSource Inc. in April 1999. NiSource Inc. was founded in 1912 and is headquartered in Merrillville, Indiana.

Atwood Oceanics, Inc. (ATW) dropped $-0.33 to close the day at a new closing price of $10.65, a -3.01% decrease in value from its previous closing price that moved the stock 90.18% above its 52 week low of $5.78. A total of 2.45M shares exchanged hands during the day compared with its three month average trading volume of 4.55M. The stock, which fluctuated between $10.56 and $11 during the day, currently situated -30.71% below its 52 week high. The stock is down by -22.99% in the past one month and up by 32.13% over the past three months. With a one year target estimate of $10.53 and RSI of 32.04, the stock still has upside potential, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

MFA Financial, Inc. (MFA) shares were up in last trading by 0.25% to $8.04. It experienced lighter than average volume on day. The stock increased in value by almost 0.12% over the past week and grew 2.81% in the past month. It is currently trading 3.27% above its 50 day moving average and 11.29% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -0.74% decrease in value from its one year high of $8.1. The RSI indicator value of 67.48, lead us to believe that it is a hold for now.

MFA Financial, Inc. operates as a real estate investment trust (REIT) in the United States. The company invests in residential mortgage assets, including agency and non-agency mortgage-backed securities (MBS), and residential whole loans, and credit risk transfer securities. Its MBS are secured by hybrid mortgages, adjustable-rate mortgages, and 15-year and longer term fixed-rate mortgages, as well as by mortgages that have interest rates that reset more frequently. The company has elected to be taxed as a REIT for the U.S. federal income tax purposes and would not be subject to income taxes, if it distributes at least 90% of its taxable income to its stockholders. MFA Financial, Inc. was founded in 1997 and is headquartered in New York, New York.

 

Three Movers to Watch for: RingCentral, Inc. (RNG), Vince Holding Corp (VNCE), Atwood Oceanics, Inc. (ATW)

RingCentral, Inc. (RNG) grew with the stock adding 0.42% or $0.1 to close at $23.9 on light trading volume of 2.63M compared its three months average trading volume of 564.19K. The Belmont California 94002 based company operating under the Application Software industry has been trending up for the last 52 weeks, with the shares price now 37.04% up for the period and up by 16.02% so far this year. With price target of $28.73 and a 72.19% rebound from 52-week low, RingCentral, Inc. has plenty of upside potential, making it a hold with a view buy.

RingCentral, Inc. provides software-as-a-service solutions for business communications primarily in the United States. The company’s products include RingCentral Office, a multi-location, multi-user, enterprise-grade communications solution that enables employees to communicate through voice, text, team messaging collaboration, HD video for Web conferencing, and fax on devices, including smartphones, tablets, PCs, and desk phones for businesses that require a communications solution; RingCentral Professional, an inbound call routing service with text and fax capabilities primarily for smaller businesses; and RingCentral Fax solution that provides Internet fax capabilities, which allow businesses to send and receive fax documents without the need for a fax machine. Its products also comprise RingCentral Contact Center, which provides a cloud based contact center solution that delivers multi-channel capabilities; and Glip by RingCentral, a team messaging and collaboration solution that allows diverse teams to stay connected through multiple modes of communication through an integration with RingCentral Office. The company serves advertising, consulting, finance, healthcare, legal, real estate, retail, and technology industries through its direct sales representatives and resellers. RingCentral, Inc. was founded in 1999 and is headquartered in Belmont, California.

Vince Holding Corp (VNCE) dropped $-0.4 to close the day at a new closing price of $2.1, a -16% decrease in value from its previous closing price that moved the stock -4.55% below its 52 week low of $1.95. A total of 2.59M shares exchanged hands during the day compared with its three month average trading volume of 582.97K. The stock, which fluctuated between $1.95 and $2.53 during the day, currently situated -74.11% below its 52 week high. The stock is down by -32.26% in the past one month and down by -58.42% over the past three months. With a one year target estimate of $4.75 and RSI of 24.26, the stock still has upside potential, making it a buy for now.

Vince Holding Corp. engages in the design, merchandise, and sale of various contemporary fashion brand products in the United States and internationally. It operates through two segments, Wholesale and Direct-To-Consumer. The company offers a range of women’s products, such as cashmere sweaters, silk blouses, leather and suede leggings and jackets, dresses, denims, tanks, T-shirts, pants, handbags, and outerwear under Vince brand; and men’s products comprising T-shirts, knit and woven tops, sweaters, denim, pants, blazers, outerwear, and leather jackets under Vince brand. It also provides women’s and men’s footwear, and children’s apparel products. The company sells its products directly to consumers through its branded specialty retail stores and outlet stores, as well as through Vince.com, an e-commerce platform; and to department stores and specialty stores. As of January 30, 2016, it operated 48 retail stores, including 34 company-operated full price stores and 14 company-operated outlet stores, as well as VINCE.com and e-commerce sites; and sold its products to consumers at approximately 2,500 distribution locations in 38 countries. The company was formerly known as Apparel Holding Corp. and changed its name to Vince Holding Corp. in November 2013. Vince Holding Corp. was founded in 2002 and is based in New York, New York.

Atwood Oceanics, Inc. (ATW) shares were up in last trading by 1.86% to $10.98. It experienced lighter than average volume on day. The stock increased in value by almost 2.62% over the past week and fell -20.72% in the past month. It is currently trading -13.9% below its 50 day moving average and 5.07% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -28.56% decrease in value from its one year high of $15.37. The RSI indicator value of 35.35, lead us to believe that it is a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

 

Eye Catching Stocks: Zions Bancorporation (ZION), Atwood Oceanics, Inc. (ATW), First Horizon National Corporation (FHN)

Zions Bancorporation (ZION) continued its upward trend with the stock climbing 1.17% or $0.51 to close the day at $44.08 on light trading volume of 2.2M shares, compared to its three month average trading volume of 2.75M. The Salt Lake City Utah 84133 based company has been outperforming the regional – pacific banks group over the past 52 weeks, with the stock gaining 112.14%, compared to the industry which has advanced 64.27% over the same period. With RSI of 58.63, the stock should still continue to rise and get closer to its one year target estimate of $45.96, making it a hold for now.

Zions Bancorporation, a financial holding company, provides a range of banking and related services in Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The company offers community banking services, such as small and medium-sized business and corporate banking; commercial and residential development, construction, and term lending; retail banking; treasury cash management and related products and services; and residential mortgage servicing and lending. It also provides trust and wealth management services; capital markets services, including municipal finance advisory and underwriting; and investment services. In addition, the company offers personal banking services to individuals, including home mortgages, bankcards, other installment loans, home equity lines of credit, checking accounts, savings accounts, certificates of deposit of various types and maturities, safe deposit facilities, direct deposits, and Internet and mobile banking services. Further, it provides online and traditional brokerage services; small business administration and secondary market agricultural real estate mortgage loans; and bond transfer, stock transfer, and escrow services for corporate customers. As of December 31, 2015, the company operated 450 domestic branches. Zions Bancorporation was founded in 1873 and is headquartered in Salt Lake City, Utah.

Atwood Oceanics, Inc. (ATW) fell -1.37% during last trading as the stock lost $-0.15 to finish the day at $10.78 with about 2.2M shares changing hands, compared to its three month average trading volume of 4.72M. The $841.27M market cap company, which fluctuated between $10.7 and $11 during the day, currently situated 112.62% above its 52 week low of $5.52 and -29.86% away from its one year high of $15.37. The RSI of 31.66 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

First Horizon National Corporation (FHN) saw its value increase by 0.81% as the stock gained $0.16 to finish the day at a closing price of $19.89. The stock was lighter in trading and has fluctuated between $11.66-$20.84 per share for the past year. The shares, which traded within a range of $19.83 to $20.15 during the day, are up by 14.38% in the past three months and up by 34.21% over the past six months. It is currently trading 0.36% above its 20 day moving average and -0.46% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $21.37 a share over the next twelve months. The current relative strength index (RSI) reading is 50.34. The technical indicator lead us to believe there will be no major movement any time soon, hold.

First Horizon National Corporation operates as the bank holding company for First Tennessee Bank National Association that provides various financial services in the United States and internationally. The company offers general banking services for consumers, businesses, financial institutions, and governments. It also provides investment, financial planning, trust, asset management, and cash management services. In addition, the company is involved in fixed income securities sales, trading, and strategies for institutional clients; underwriting of bank-eligible securities and other fixed-income securities eligible for underwriting by financial subsidiaries; loan sales; derivative sales; and provision of portfolio advisory services. Further, it offers discount brokerage and full-service brokerage services; correspondent banking services; transaction processing services comprising nationwide check clearing and remittance processing services; trust, fiduciary, and agency services; credit card products; equipment finance; and investment and financial advisory services. Additionally, the company engages in mutual fund and retail insurance sales, as well as provides mortgage banking services. As of December 31, 2015, it had 185 branch locations in 8 states, including 166 branches in Tennessee; 2 branches in northwestern Georgia; 6 branches in northwestern Mississippi; 7 branches in North Carolina; and 1 branch each in Virginia, South Carolina, Florida, and Texas. The company was founded in 1968 and is headquartered in Memphis, Tennessee.

 

Stocks on Trader’s Radar: Atwood Oceanics, Inc. (ATW), Galena Biopharma, Inc. (GALE), First Bancorp (FBP)

Atwood Oceanics, Inc. (ATW) managed to rebound with the stock climbing 3.11% or $0.33 to close the day at $10.93 on light trading volume of 4.21M shares, compared to its three month average trading volume of 4.75M. The Houston Texas 77094 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 96.58%, compared to the industry which has advanced 112.9% over the same period. With RSI of 33.19, the stock should still continue to rise and get closer to its one year target estimate of $10.53, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Galena Biopharma, Inc. (GALE) fell -9.34% during last trading as the stock lost $-0.08 to finish the day at $0.74 with about 4.18M shares changing hands, compared to its three month average trading volume of 2.11M. The $12.5M market cap company, which fluctuated between $0.72 and $0.8042 during the day, currently situated -8.22% below its 52 week low of $0.16 and -98.51% away from its one year high of $4.75. The RSI of 23.92 indicates the stock is oversold at the current levels, buy for now.

Galena Biopharma, Inc., a biopharmaceutical company, focuses on developing and commercializing oncology therapeutics that address major unmet medical needs. The company’s lead product candidate, NeuVax (nelipepimut-S), is in Phase III clinical trials for the prevention of recurrence in early- stage and node-positive breast cancer with low to intermediate human epidermal growth factor receptor (HER2) expression; Phase IIb clinical trials in combination with Herceptin for HER2 1+/2+ node-positive and high-risk node-negative breast cancer treatment; and Phase II clinical trials in combination with trastuzumab for node positive and negative HER2 IHC 3+ patients. It also develops GALE-301 (folate binding protein), which is in Phase IIa clinical trials for the prevention of recurrence in patients with ovarian and endometrial cancers; GALE-302, a version of the E39 peptide that is in Phase 1b clinical trial for investigating a novel vaccination series; and GALE-401 (anagrelide controlled release), which is in a Phase II clinical trial for the treatment of patients with myeloproliferative neoplasms to lower elevated platelet levels. Galena Biopharma, Inc. has strategic development and commercialization partnership with Dr. Reddy’s Laboratories Ltd. for NeuVax in breast and gastric cancers. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Galena Biopharma, Inc. in September 2011. Galena Biopharma, Inc. was founded in 2003 and is based in San Ramon, California.

First Bancorp (FBP) saw its value decrease by -0.45% as the stock dropped $-0.03 to finish the day at a closing price of $6.62. The stock was higher in trading and has fluctuated between $2.22-$7.05 per share for the past year. The shares, which traded within a range of $6.54 to $6.69 during the day, are up by 23.05% in the past three months and up by 52.89% over the past six months. It is currently trading -0.46% below its 20 day moving average and 0.63% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $7.58 a share over the next twelve months. The current relative strength index (RSI) reading is 49.68. The technical indicator lead us to believe there will be no major movement any time soon, hold.

First BanCorp. operates as the bank holding company for FirstBank Puerto Rico that provides a range of financial products and services to retail, commercial, and institutional clients. Its Commercial and Corporate Banking segment offers commercial real estate and construction loans, and floor plan financings; and cash and business management services, as well as underwrites municipal securities and provides financial advisory services. The company’s Consumer (Retail) Banking segment offers auto, boat, and personal loans; credit cards; lines of credit; and deposit products comprising interest bearing and non-interest bearing checking and savings accounts, individual retirement accounts, and retail certificates of deposit, as well as engages in the finance leasing and insurance activities. Its Mortgage Banking segment is involved in the origination, sale, securitization, and servicing of various residential mortgage loan products and related hedging activities; acquisition and sale of mortgages in the secondary markets; and provision of mortgage loans purchased from other local banks and mortgage bankers. The company’s Treasury and Investments segment engages in the treasury and investment management activities, such as funding and liquidity management. Its United States Operations segment offers checking, savings, and money market accounts; and residential mortgages, home equity loans, lines of credit, and automobile loans, as well as retail certificates of deposits, Internet banking services, remote data capture, automated clearing house transactions, and commercial real estate products. The company’s Virgin Islands Operations segment is involved in the consumer, commercial lending, and deposit-taking activities. As of December 31, 2015, it operated 51 branches in Puerto Rico, 11 branches in the U.S. Virgin Islands and British Virgin Islands, and 10 branches in the state of Florida. The company was founded in 1948 and is headquartered in Santurce, Puerto Rico.

 

Stocks In Queue: Atwood Oceanics, Inc. (ATW), Acura Pharmaceuticals, Inc. (ACUR), Array BioPharma Inc. (ARRY)

Atwood Oceanics, Inc. (ATW) climbed 1.4% during last trading as the stock added $0.15 to finish the day at $10.85 with about 5.52M shares changing hands, compared to its three month average trading volume of 4.75M. The $815.49M market cap company, which fluctuated between $10.31 and $10.91 during the day, currently situated 114.% above its 52 week low of $5.07 and -29.41% away from its one year high of $15.37. The RSI of 32.32 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Acura Pharmaceuticals, Inc. (ACUR) dropped $-0.38 to close the day at a new closing price of $0.92, a -29.23% decrease in value from its previous closing price that moved the stock 85.86% above its 52 week low of $0.5. A total of 5.14M shares exchanged hands during the day compared with its three month average trading volume of 315.31K. The stock, which fluctuated between $0.86 and $1.4 during the day, currently situated -73.86% below its 52 week high. The stock is up by 34.8% in the past one month and down by 0% over the past three months. With a one year target estimate of $6 and RSI of 58.09, the stock still has upside potential, making it a hold for now.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, researches, develops, and commercializes products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; Egalet Ltd.; and Egalet Corporation to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.

Array BioPharma Inc. (ARRY) had a active trading with around 4.93M shares changing hands compared to its three month average trading volume of 4.1M. The stock traded between $10.4 and $10.97 before closing at the price of $10.7 with 1.61% change on the day. The Boulder Colorado 80301 based company is currently trading 349.58% above its 52 week low of $2.38 and -8.15% below its 52 week high of $11.65. Both the RSI indicator and target price of 56.2 and $11.63 respectively, lead us to believe that it should be put on hold over the coming weeks.

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. The company’s drugs in Phase III clinical trials include Binimetinib, Encorafenib, and Selumetinib for the treatment of cancer, as well as ASC08/Danoprevir, a protease inhibitor for hepatitis C virus. Its drug candidates in Phase II clinical trials comprise Filanesib, a kinesin spindle protein inhibitor for multiple myeloma; ARRY-797, a p38 inhibitor for Lamin A/C-related dilated cardiomyopathy; ASLAN001/Varlitinib, a pan-HER2 inhibitor for gastric or breast cancer; Ipatasertib/GDC-0068, an AKT inhibitor for cancer; Motolimod/VTX-2337, a toll-like receptor for cancer; Prexasertib/LY2606368, a chk-1 inhibitor for cancer; LOXO-101, a PanTrk inhibitor for cancer; and ONT-380/ARRY-380, an HER2 inhibitor for breast cancer. The company’s Phase I drugs include GDC-0994, an ERK inhibitor for cancer; and ARRY-382, a CSF1R inhibitor for cancer, as well as Phase Ib drug candidate comprises GDC-0575, a chk-1 inhibitor for cancer. Array BioPharma Inc. was founded in 1998 and is headquartered in Boulder, Colorado.

 

Stock’s Trend Analysis Report: Vanguard Natural Resources, LLC (VNR), Atwood Oceanics, Inc. (ATW), Fitbit, Inc. (FIT)

Vanguard Natural Resources, LLC (VNR) fell -34.71% during last trading as the stock lost $-0.11 to finish the day at $0.19 with about 15.88M shares changing hands, compared to its three month average trading volume of 3.45M. The $31.62M market cap company, which fluctuated between $0.17 and $0.29 during the day, currently situated -24.34% below its 52 week low of $0.17 and -92.8% away from its one year high of $2.68. The RSI of 23.25 indicates the stock is oversold at the current levels, buy for now.

Vanguard Natural Resources, LLC, through its subsidiaries, acquires and develops oil and natural gas properties in the United States. It owns properties, and oil and natural gas reserves primarily located in 10 operating basins, including the Green River Basin in Wyoming; the Permian Basin in West Texas and New Mexico; the Gulf Coast Basin in Texas, Louisiana, Mississippi, and Alabama; the Anadarko Basin in Oklahoma and North Texas; the Piceance Basin in Colorado; the Big Horn Basin in Wyoming and Montana; the Arkoma Basin in Arkansas and Oklahoma; the Williston Basin in North Dakota and Montana; the Wind River Basin in Wyoming; and the Powder River Basin in Wyoming. As of December 31, 2015, the company had total estimated proved reserves of 2,289.3 million barrels of oil equivalent, as well as owned working interests in 14,459 gross productive wells and approximately 881,508 gross undeveloped acres. Vanguard Natural Resources, LLC was founded in 2006 and is headquartered in Houston, Texas. On February 1, 2017, Vanguard Natural Resources, LLC, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

Atwood Oceanics, Inc. (ATW) dropped $-1.74 to close the day at a new closing price of $10.91, a -13.75% decrease in value from its previous closing price that moved the stock 115.19% above its 52 week low of $5.07. A total of 10.28M shares exchanged hands during the day compared with its three month average trading volume of 4.56M. The stock, which fluctuated between $10.85 and $12.35 during the day, currently situated -29.02% below its 52 week high. The stock is down by -16.08% in the past one month and up by 46.84% over the past three months. With a one year target estimate of $10.7 and RSI of 31.97, the stock still has upside potential, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Fitbit, Inc. (FIT) had a light trading with around 10.21M shares changing hands compared to its three month average trading volume of 11.8M. The stock traded between $5.94 and $6.09 before closing at the price of $5.95 with -2.3% change on the day. The San Francisco California 94105 based company is currently trading 2.41% above its 52 week low of $5.81 and -68.44% below its 52 week high of $18.85. Both the RSI indicator and target price of 27.07 and $8 respectively, lead us to believe that it could rise over the coming weeks.

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the user’s phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

 

Stocks Highlights: First Bancorp (FBP), Atwood Oceanics, Inc. (ATW), Brookdale Senior Living Inc. (BKD)

First Bancorp (FBP) had a active trading with around 3.79M shares changing hands compared to its three month average trading volume of 1.76M. The stock traded between $6.43 and $6.61 before closing at the price of $6.59 with 2.33% change on the day. The San Juan 00908 based company is currently trading 215.31% above its 52 week low of $2.09 and -6.52% below its 52 week high of $7.05. Both the RSI indicator and target price of 49.57 and $7.7 respectively, lead us to believe that it should be put on hold over the coming weeks.

First BanCorp. operates as the bank holding company for FirstBank Puerto Rico that provides a range of financial products and services to retail, commercial, and institutional clients. Its Commercial and Corporate Banking segment offers commercial real estate and construction loans, and floor plan financings; and cash and business management services, as well as underwrites municipal securities and provides financial advisory services. The company’s Consumer (Retail) Banking segment offers auto, boat, and personal loans; credit cards; lines of credit; and deposit products comprising interest bearing and non-interest bearing checking and savings accounts, individual retirement accounts, and retail certificates of deposit, as well as engages in the finance leasing and insurance activities. Its Mortgage Banking segment is involved in the origination, sale, securitization, and servicing of various residential mortgage loan products and related hedging activities; acquisition and sale of mortgages in the secondary markets; and provision of mortgage loans purchased from other local banks and mortgage bankers. The company’s Treasury and Investments segment engages in the treasury and investment management activities, such as funding and liquidity management. Its United States Operations segment offers checking, savings, and money market accounts; and residential mortgages, home equity loans, lines of credit, and automobile loans, as well as retail certificates of deposits, Internet banking services, remote data capture, automated clearing house transactions, and commercial real estate products. The company’s Virgin Islands Operations segment is involved in the consumer, commercial lending, and deposit-taking activities. As of December 31, 2015, it operated 51 branches in Puerto Rico, 11 branches in the U.S. Virgin Islands and British Virgin Islands, and 10 branches in the state of Florida. The company was founded in 1948 and is headquartered in Santurce, Puerto Rico.

Atwood Oceanics, Inc. (ATW) managed to rebound with the stock climbing 4.37% or $0.53 to close the day at $12.65 on light trading volume of 3.78M shares, compared to its three month average trading volume of 4.55M. The Houston Texas 77094 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 87.41%, compared to the industry which has advanced 90.23% over the same period. With RSI of 48.19, the stock should still continue to rise and get closer to its one year target estimate of $10.7, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Brookdale Senior Living Inc. (BKD) shares were down in last trading by -0.06% to $15.43. It experienced lighter than average volume on day. The stock increased in value by almost 4.4% over the past week and grew 16.72% in the past month. It is currently trading 15.04% above its 50 day moving average and -2.64% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -20.55% decrease in value from its one year high of $19.42. The RSI indicator value of 62.69, lead us to believe that it is a hold for now.

Brookdale Senior Living Inc. owns and operates senior living communities in the United States. It operates through five segments: Retirement Centers, Assisted Living, Continuing Care Retirement Centers (CCRCs) – Rental, Brookdale Ancillary Services, and Management Services. The Retirement Centers segment owns or leases communities comprising independent living and assisted living units in a single community that are primarily designed for middle to upper income senior citizens. The Assisted Living segment owns or leases communities consisting of freestanding, multi-story communities, and freestanding single story communities, which offer housing and 24-hour assistance with activities of daily life to mid-acuity frail and elderly residents. This segment also operates memory care communities for residents with Alzheimer’s disease and other dementias. The CCRCs – Rental segment owns or leases communities that offer various living arrangements and services to accommodate various levels of physical ability and health. The Brookdale Ancillary Services segment provides outpatient therapy, home health, and hospice services to residents of its communities, as well as to other senior living communities. The Management Services segment operates communities under the management agreements. As of December 31, 2015, the company operated 130 retirement center communities with 24,486 units; 915 assisted living communities with 62,567 units; and 78 CCRCs with 21,367 units, as well as owned or leased 959 communities with 81,067 units and provided management services with respect to 164 communities with 27,353 units for third parties or unconsolidated ventures. Brookdale Senior Living Inc. is headquartered in Brentwood, Tennessee.

 

Traders Recap: Celldex Therapeutics, Inc. (CLDX), Synergy Resources Corporation (SYRG), Atwood Oceanics, Inc. (ATW)

Celldex Therapeutics, Inc. (CLDX) managed to rebound with the stock climbing 4.35% or $0.14 to close the day at $3.36 on higher than average trading volume of 4.21M shares, compared to its three month average trading volume of 2.27M. The Hampton New Jersey 08827 based company has been outperforming the biotechnology companies by 7.6695% for last three months and its recent gains have offset losses to -5.08% YTD, versus the biotechnology industry which is down -6.44% for the same period. The RSI of 44.38 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care. The company’s lead drug candidates comprise Rintega (CDX-110), a therapeutic vaccine in Phase III clinical studies for the treatment of glioblastoma patients that express an epidermal growth factor receptor variant III, as well as in Phase II study for the treatment of recurrent glioblastoma; Glembatumumab vedotin (CDX-011), a targeted antibody-drug conjugate (ADC) in a randomized Phase IIb study for the treatment of triple negative breast cancer, as well as in Phase II study for the treatment of metastatic melanoma; and Varlilumab (CDX-1127), an immune modulating antibody is in Phase I study for the treatment of multiple solid tumors. It also has various earlier stage drug candidates in clinical development, including CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells for cancer indications; CDX-301, an immune cell mobilizing agent and dendritic cell growth factor; and CDX-014, a fully-human monoclonal ADC that targets T cell immunoglobulin and mucin domain 1, a molecule, which is upregulated in various cancers comprising renal cell and ovarian carcinomas. In addition, the company is developing CDX-0158, which is in a Phase I dose escalation study in refractory gastrointestinal stromal tumors; CDX-3379 that completed a Phase Ib study for adult patients with advanced solid tumors; and a multi-faceted TAM program to generate antibodies that modulate the TAM family of RTKs comprising of Tyro3, AXL, and MerTK. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc., as well as clinical trial collaboration with Roche Holding. The company is headquartered in Hampton, New Jersey.

Synergy Resources Corporation (SYRG) had a active trading with around 4.17M shares changing hands compared to its three month average trading volume of 3.83M. The stock traded between $8.77 and $9.06 before closing at the price of $8.9 with 0.45% change on the day. The Denver Colorado 80202 based company is currently trading 77.64% above its 52 week low of $5.01 and -14.26% below its 52 week high of $10.38. Both the RSI indicator and target price of 52.14 and $10.48 respectively, lead us to believe that it should be put on hold over the coming weeks.

Synergy Resources Corporation engages in the acquisition, development, exploitation, exploration, and production of oil and natural gas properties primarily located in the Denver-Julesburg Basin in Colorado. As of December 31, 2015, the company had approximately 349,000 net acres under lease, which are located in the Wattenberg Field of the Denver-Julesburg Basin; and operated 369 net producing wells. It also has mineral assets in Yuma and Washington Counties, Colorado. Synergy Resources Corporation is based in Denver, Colorado.

Atwood Oceanics, Inc. (ATW) traded within a range of $11.72 to $12.31 after opening the day at $12.18. The company has seen its stock decrease in value by -7.69% so far this year. The stock was down close to -0.16% on light volume in last trading session and closed at $12.12 per share. After the recent fall, the stock is currently holding -21.15% below its 52 week high of $15.37 and 151.45% above its 12-month low of $5.07. The shares are up by over 57.81% in the last three months, and the RSI indicator value of 40.89 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

 

3 Trending Stocks: Atwood Oceanics, Inc. (ATW), Gentex Corporation (GNTX), Antero Resources Corporation (AR)

Atwood Oceanics, Inc. (ATW) continued its downward trend with the stock declining -0.16% or $-0.02 to close the day at $12.14 on light trading volume of 3.53M shares, compared to its three month average trading volume of 4.52M. The Houston Texas 77094 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 128.2%, compared to the industry which has advanced 103.39% over the same period. With RSI of 40.01, the stock should still continue to rise and get closer to its one year target estimate of $10.17, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Gentex Corporation (GNTX) fell -1.15% during last trading as the stock lost $-0.24 to finish the day at $20.65 with about 3.53M shares changing hands, compared to its three month average trading volume of 2.21M. The $5.92B market cap company, which fluctuated between $20.53 and $21 during the day, currently situated 61.98% above its 52 week low of $13.02 and -5.66% away from its one year high of $21.89. The RSI of 50.76 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Gentex Corporation designs, develops, manufactures, and markets automatic-dimming rearview mirrors and electronics for the automotive industry; dimmable aircraft windows for the aviation industry; and commercial smoke alarms and signaling devices for the fire protection industry worldwide. It offers automotive products, including interior and exterior electrochromic automatic-dimming rearview mirrors, automotive electronics, and interior and exterior non-automatic-dimming rearview mirrors with electronic features for automotive passenger cars, light trucks, pick-up trucks, sport utility vehicles, and vans for original equipment manufacturers, tier one automotive mirror manufacturers, and various aftermarket and accessory customers. The company also provides photoelectric smoke detectors and alarms, audible and visual signaling alarms, electrochemical carbon monoxide detectors and alarms, and bells and speakers for use in fire detection systems in office buildings, hotels, and other commercial and residential establishments. Gentex Corporation sells its fire protection products directly, as well as through sales managers and manufacturer representative organizations to fire protection and security product distributors, electrical wholesale houses, and original equipment manufacturers of fire protection systems. The company was founded in 1974 and is headquartered in Zeeland, Michigan.

Antero Resources Corporation (AR) saw its value increase by 0.98% as the stock gained $0.24 to finish the day at a closing price of $24.65. The stock was lighter in trading and has fluctuated between $21.45-$30.66 per share for the past year. The shares, which traded within a range of $24.47 to $24.89 during the day, are down by -6.88% in the past three months and down by -5.34% over the past six months. It is currently trading -1.85% below its 20 day moving average and -1.62% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $34.3 a share over the next twelve months. The current relative strength index (RSI) reading is 45.03. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Antero Resources Corporation, an independent oil and natural gas company, acquires, explores, and develops natural gas, natural gas liquids, and oil properties in the United States. As of December 31, 2015, the company had 569,000 net acres of oil and gas properties located in the Appalachian Basin in West Virginia, Ohio, and Pennsylvania. It also owned and operated 182 miles of gas gathering pipelines in the Marcellus Shale; and 110 miles of low-pressure, high-pressure, and condensate pipelines in the Utica Shale. The company was formerly known as Antero Resources Appalachian Corporation and changed its name to Antero Resources Corporation in June 2013. Antero Resources Corporation was founded in 2002 and is headquartered in Denver, Colorado. Antero Resources Corporation is a subsidiary of Antero Resources Investment LLC.

 

Stocks Highlights: SUPERVALU Inc. (SVU), Atwood Oceanics, Inc. (ATW), Celldex Therapeutics, Inc. (CLDX)

SUPERVALU Inc. (SVU) had a active trading with around 5.21M shares changing hands compared to its three month average trading volume of 3.92M. The stock traded between $3.83 and $3.99 before closing at the price of $3.92 with 1.55% change on the day. The Eden Prairie Minnesota 55344 based company is currently trading 2.89% above its 52 week low of $3.81 and -36.47% below its 52 week high of $6.17. Both the RSI indicator and target price of 31.78 and $5.04 respectively, lead us to believe that it should be put on hold over the coming weeks.

SUPERVALU INC., together with its subsidiaries, operates as a grocery wholesaler and retailer in the United States. The company operates through three segments: Wholesale, Save-A-Lot, and Retail. The Wholesale segment offers wholesale distribution of various food and non-food products to independent retail customers, such as single and multiple grocery store independent operators, regional chains, and the military. This segment operates approximately 1,796 stores with a network spanning 40 states. The Save-A-Lot segment owns, operates, and licenses 1,360 discount grocery stores under the Save-A-Lot banner, including 897 licensed Save-A-Lot stores and 463 company-operated stores. The Retail segment operates retail stores that provide groceries and various additional products, including general merchandise, home, health and beauty care, and pharmacy products. This segment operates 200 stores under the Cub Foods, Shoppers Food & Pharmacy, Shop ’n Save, Farm Fresh, and Hornbacher’s banners, as well as 2 Rainbow and 2 County Market stores. The company provides a range of brand name and private-label products comprising perishable and nonperishable grocery products. SUPERVALU INC. was founded in 1871 and is headquartered in Eden Prairie, Minnesota.

Atwood Oceanics, Inc. (ATW) continued its downward trend with the stock declining -0.16% or $-0.02 to close the day at $12.16 on active trading volume of 5.2M shares, compared to its three month average trading volume of 4.5M. The Houston Texas 77094 based company has been outperforming the oil & gas drilling & exploration group over the past 52 weeks, with the stock gaining 113.71%, compared to the industry which has advanced 91.63% over the same period. With RSI of 41.31, the stock should still continue to rise and get closer to its one year target estimate of $10.17, making it a hold for now.

Atwood Oceanics, Inc., an offshore drilling contractor, engages in the drilling and completion of exploratory and developmental oil and gas wells. As of November 11, 2016, it owned a fleet of 10 mobile offshore drilling units. The company operates its fleet in the United States, Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshore Southeast Asia, and offshore Australia. Atwood Oceanics, Inc. was founded in 1968 and is headquartered in Houston, Texas.

Celldex Therapeutics, Inc. (CLDX) shares were up in last trading by 0.31% to $3.26. It experienced higher than average volume on day. The stock decreased in value by almost -2.1% over the past week and fell -8.43% in the past month. It is currently trading -13.66% below its 50 day moving average and -18.29% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -62.74% decrease in value from its one year high of $8.75. The RSI indicator value of 34.75, lead us to believe that it is a hold for now.

Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care. The company’s lead drug candidates comprise Rintega (CDX-110), a therapeutic vaccine in Phase III clinical studies for the treatment of glioblastoma patients that express an epidermal growth factor receptor variant III, as well as in Phase II study for the treatment of recurrent glioblastoma; Glembatumumab vedotin (CDX-011), a targeted antibody-drug conjugate (ADC) in a randomized Phase IIb study for the treatment of triple negative breast cancer, as well as in Phase II study for the treatment of metastatic melanoma; and Varlilumab (CDX-1127), an immune modulating antibody is in Phase I study for the treatment of multiple solid tumors. It also has various earlier stage drug candidates in clinical development, including CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells for cancer indications; CDX-301, an immune cell mobilizing agent and dendritic cell growth factor; and CDX-014, a fully-human monoclonal ADC that targets T cell immunoglobulin and mucin domain 1, a molecule, which is upregulated in various cancers comprising renal cell and ovarian carcinomas. In addition, the company is developing CDX-0158, which is in a Phase I dose escalation study in refractory gastrointestinal stromal tumors; CDX-3379 that completed a Phase Ib study for adult patients with advanced solid tumors; and a multi-faceted TAM program to generate antibodies that modulate the TAM family of RTKs comprising of Tyro3, AXL, and MerTK. It has research collaboration and license agreements with Medarex, Inc.; Rockefeller University; Duke University Brain Tumor Cancer Center; Ludwig Institute for Cancer Research; Alteris Therapeutics, Inc.; University of Southampton; Amgen Inc.; Amgen Fremont; and Seattle Genetics, Inc., as well as clinical trial collaboration with Roche Holding. The company is headquartered in Hampton, New Jersey.